Skip to content

NPS Pharmaceuticals’ CEO Dr. Francois Nader Discusses Orphan Drug Gattex (Teduglutide): YouTube Video

December 12, 2012

       Dr. Francois Nader, President & CEO of NPS Pharmaceuticals, speaks with Avik Roy, a Forbes contributor, at the December 4 – 5, 2012, Forbes Healthcare Summit in New York City. Dr. Nader discusses the developments of orphan drug Gattex (Teduglutide) for the treatment of Short Bowel Syndrome (SBS). 

              In October 2012, Jim Cramer, from CNBC, interviews Dr. Francois Nader, on the topic of orphan drugs. 

Upcoming Catalyst

  1. FDA PDUFA Date of December 30, 2012


Copyright © 2012-2013, Orphan Druganaut Blog.  All rights reserved.

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: